The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 7
  • 1
    Soni, Ashok
    Pharmacist born in July 1961
    Individual (11 offsprings)
    Officer
    2024-07-01 ~ now
    OF - Director → CIF 0
  • 2
    Kamenica, Gerti
    Superintendent Pharmacist born in August 1983
    Individual (1 offspring)
    Officer
    2017-01-01 ~ now
    OF - Director → CIF 0
  • 3
    Hogan, Philip Richard
    Director born in January 1959
    Individual (2 offsprings)
    Officer
    2024-11-01 ~ now
    OF - Director → CIF 0
  • 4
    Butt, Jamal Masood
    Consultant born in January 1966
    Individual (3 offsprings)
    Officer
    2024-04-01 ~ now
    OF - Director → CIF 0
  • 5
    Bloom, Shoshana Rachel
    Management Consultant born in February 1973
    Individual (2 offsprings)
    Officer
    2020-07-20 ~ now
    OF - Director → CIF 0
  • 6
    England, Alice Maisy Louise
    Pharmacist born in January 1994
    Individual (1 offspring)
    Officer
    2024-07-30 ~ now
    OF - Director → CIF 0
  • 7
    Worthing Hospital, Lyndhurst Road, Worthing, England
    Corporate (1 offspring)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 12
  • 1
    Anderson, Gary Mark
    Management Consultant born in June 1961
    Individual (9 offsprings)
    Officer
    2016-06-01 ~ 2024-11-30
    OF - Director → CIF 0
  • 2
    Harchowai, Jatinder Singh
    Hospital Pharmacist born in August 1969
    Individual
    Officer
    2014-01-13 ~ 2014-10-27
    OF - Director → CIF 0
  • 3
    Prosser, Spencer
    Finance Director Nhs born in July 1965
    Individual
    Officer
    2014-01-13 ~ 2017-03-31
    OF - Director → CIF 0
  • 4
    Nerney, Julie Claire
    Chartered Director born in November 1971
    Individual (6 offsprings)
    Officer
    2014-11-24 ~ 2018-11-30
    OF - Director → CIF 0
    2019-04-01 ~ 2020-01-31
    OF - Director → CIF 0
  • 5
    Fadero, Amanda Therese
    Nhs Manager born in July 1960
    Individual (1 offspring)
    Officer
    2014-10-26 ~ 2016-04-30
    OF - Director → CIF 0
  • 6
    Okorie, Michael, Dr
    Consultant Physician born in July 1971
    Individual
    Officer
    2020-08-05 ~ 2024-11-01
    OF - Director → CIF 0
  • 7
    Stafford, Clare
    Accountant born in November 1971
    Individual
    Officer
    2018-01-22 ~ 2020-08-05
    OF - Director → CIF 0
  • 8
    Kershaw, Matthew David
    Chief Executive Nhs born in July 1970
    Individual
    Officer
    2014-01-13 ~ 2014-10-27
    OF - Director → CIF 0
  • 9
    O'kane, Ciara
    Pharmacist born in December 1981
    Individual
    Officer
    2014-10-27 ~ 2016-12-31
    OF - Director → CIF 0
  • 10
    Baldwin, Steven John
    Superintendent Pharmacist born in May 1979
    Individual
    Officer
    2014-01-13 ~ 2018-09-30
    OF - Director → CIF 0
  • 11
    Ford, Dominic John
    Nhs Director Of Corporate born in November 1964
    Individual
    Officer
    2014-01-13 ~ 2017-08-30
    OF - Director → CIF 0
    Ford, Dominic John
    Individual
    Officer
    2014-01-13 ~ 2017-08-30
    OF - Secretary → CIF 0
  • 12
    Wilks, Martyn Kevin
    Non Executive Director born in February 1958
    Individual (1 offspring)
    Officer
    2016-06-01 ~ 2023-06-30
    OF - Director → CIF 0
parent relation
Company in focus

PHARM@SEA LIMITED

Standard Industrial Classification
86101 - Hospital Activities
Brief company account
Par Value of Share
Class 1 ordinary share
12023-04-01 ~ 2024-03-31
Turnover/Revenue
24,111,605 GBP2023-04-01 ~ 2024-03-31
23,820,611 GBP2022-04-01 ~ 2023-03-31
Cost of Sales
21,386,588 GBP2023-04-01 ~ 2024-03-31
19,991,180 GBP2022-04-01 ~ 2023-03-31
Gross Profit/Loss
2,725,017 GBP2023-04-01 ~ 2024-03-31
3,829,431 GBP2022-04-01 ~ 2023-03-31
Administrative Expenses
1,730,557 GBP2023-04-01 ~ 2024-03-31
1,465,819 GBP2022-04-01 ~ 2023-03-31
Operating Profit/Loss
994,460 GBP2023-04-01 ~ 2024-03-31
2,363,612 GBP2022-04-01 ~ 2023-03-31
Other Interest Receivable/Similar Income (Finance Income)
91,073 GBP2023-04-01 ~ 2024-03-31
904 GBP2022-04-01 ~ 2023-03-31
Interest Payable/Similar Charges (Finance Costs)
1,028 GBP2023-04-01 ~ 2024-03-31
457 GBP2022-04-01 ~ 2023-03-31
Profit/Loss on Ordinary Activities Before Tax
1,084,505 GBP2023-04-01 ~ 2024-03-31
2,364,059 GBP2022-04-01 ~ 2023-03-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
273,229 GBP2023-04-01 ~ 2024-03-31
449,088 GBP2022-04-01 ~ 2023-03-31
Profit/Loss
811,276 GBP2023-04-01 ~ 2024-03-31
1,914,971 GBP2022-04-01 ~ 2023-03-31
Comprehensive Income/Expense
811,276 GBP2023-04-01 ~ 2024-03-31
1,914,971 GBP2022-04-01 ~ 2023-03-31
Property, Plant & Equipment
133,450 GBP2024-03-31
138,732 GBP2023-03-31
Total Inventories
1,020,024 GBP2024-03-31
793,232 GBP2023-03-31
Debtors
4,401,783 GBP2024-03-31
2,948,182 GBP2023-03-31
Cash at bank and in hand
407,108 GBP2024-03-31
1,911,100 GBP2023-03-31
Current Assets
5,828,915 GBP2024-03-31
5,652,514 GBP2023-03-31
Creditors
Current
2,859,144 GBP2024-03-31
2,796,868 GBP2023-03-31
Net Current Assets/Liabilities
2,969,771 GBP2024-03-31
2,855,646 GBP2023-03-31
Total Assets Less Current Liabilities
3,103,221 GBP2024-03-31
2,994,378 GBP2023-03-31
Creditors
Non-current
-40,900 GBP2024-03-31
-43,355 GBP2023-03-31
Net Assets/Liabilities
3,039,696 GBP2024-03-31
2,928,420 GBP2023-03-31
Equity
Called up share capital
1,101,000 GBP2024-03-31
1,101,000 GBP2023-03-31
1,101,000 GBP2022-03-31
Retained earnings (accumulated losses)
1,938,696 GBP2024-03-31
1,827,420 GBP2023-03-31
912,449 GBP2022-03-31
Equity
3,039,696 GBP2024-03-31
2,928,420 GBP2023-03-31
2,013,449 GBP2022-03-31
Dividends Paid
Retained earnings (accumulated losses)
-700,000 GBP2023-04-01 ~ 2024-03-31
-1,000,000 GBP2022-04-01 ~ 2023-03-31
Dividends Paid
-700,000 GBP2023-04-01 ~ 2024-03-31
-1,000,000 GBP2022-04-01 ~ 2023-03-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
811,276 GBP2023-04-01 ~ 2024-03-31
1,914,971 GBP2022-04-01 ~ 2023-03-31
Wages/Salaries
1,169,090 GBP2023-04-01 ~ 2024-03-31
846,011 GBP2022-04-01 ~ 2023-03-31
Social Security Costs
91,920 GBP2023-04-01 ~ 2024-03-31
76,360 GBP2022-04-01 ~ 2023-03-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
32,933 GBP2023-04-01 ~ 2024-03-31
24,125 GBP2022-04-01 ~ 2023-03-31
Staff Costs/Employee Benefits Expense
1,293,943 GBP2023-04-01 ~ 2024-03-31
946,496 GBP2022-04-01 ~ 2023-03-31
Average Number of Employees
352023-04-01 ~ 2024-03-31
302022-04-01 ~ 2023-03-31
Director Remuneration
171,489 GBP2023-04-01 ~ 2024-03-31
164,267 GBP2022-04-01 ~ 2023-03-31
Property, Plant & Equipment - Depreciation Expense
Owned assets
18,988 GBP2023-04-01 ~ 2024-03-31
18,384 GBP2022-04-01 ~ 2023-03-31
Audit Fees/Expenses
23,800 GBP2023-04-01 ~ 2024-03-31
23,613 GBP2022-04-01 ~ 2023-03-31
Current Tax for the Period
273,207 GBP2023-04-01 ~ 2024-03-31
449,088 GBP2022-04-01 ~ 2023-03-31
Tax Expense/Credit at Applicable Tax Rate
271,126 GBP2023-04-01 ~ 2024-03-31
449,171 GBP2022-04-01 ~ 2023-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
438,233 GBP2024-03-31
438,233 GBP2023-03-31
Motor vehicles
32,072 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
523,996 GBP2024-03-31
53,691 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
366,811 GBP2024-03-31
347,823 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
390,546 GBP2024-03-31
353,192 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
18,988 GBP2023-04-01 ~ 2024-03-31
Motor vehicles
12,997 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
37,354 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Motor vehicles
12,997 GBP2024-03-31
Property, Plant & Equipment
Plant and equipment
71,422 GBP2024-03-31
90,410 GBP2023-03-31
Motor vehicles
19,075 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Motor vehicles, Under hire purchased contracts or finance leases
12,997 GBP2023-04-01 ~ 2024-03-31
Under hire purchased contracts or finance leases
18,366 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment
Motor vehicles, Under hire purchased contracts or finance leases
19,075 GBP2024-03-31
Under hire purchased contracts or finance leases
62,028 GBP2024-03-31
48,322 GBP2023-03-31
Merchandise
1,020,024 GBP2024-03-31
793,232 GBP2023-03-31
Trade Debtors/Trade Receivables
Current
3,653,002 GBP2024-03-31
2,367,003 GBP2023-03-31
Other Debtors
Current
4,812 GBP2024-03-31
Amount of value-added tax that is recoverable
Current
609,124 GBP2024-03-31
568,777 GBP2023-03-31
Prepayments
Current
134,845 GBP2024-03-31
12,402 GBP2023-03-31
Debtors
Current, Amounts falling due within one year
4,401,783 GBP2024-03-31
2,948,182 GBP2023-03-31
Finance Lease Liabilities - Total Present Value
Current
18,090 GBP2024-03-31
5,192 GBP2023-03-31
Trade Creditors/Trade Payables
Current
1,346,200 GBP2024-03-31
249,221 GBP2023-03-31
Corporation Tax Payable
Current
273,208 GBP2024-03-31
453,685 GBP2023-03-31
Other Taxation & Social Security Payable
Current
25,074 GBP2024-03-31
22,786 GBP2023-03-31
Other Creditors
Current
705,752 GBP2024-03-31
1,004,124 GBP2023-03-31
Accrued Liabilities
Current
490,820 GBP2024-03-31
1,061,860 GBP2023-03-31
Finance Lease Liabilities - Total Present Value
Non-current
40,900 GBP2024-03-31
43,355 GBP2023-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
52,649 GBP2024-03-31
52,649 GBP2023-03-31
Between one and five year
52,649 GBP2024-03-31
105,298 GBP2023-03-31
All periods
105,298 GBP2024-03-31
157,947 GBP2023-03-31
Amounts set aside to cover potential liabilities or losses
Deferred taxation
22,625 GBP2024-03-31
22,603 GBP2023-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,101,000 shares2024-03-31
Profit/Loss
Retained earnings (accumulated losses)
811,276 GBP2023-04-01 ~ 2024-03-31
  • PHARM@SEA LIMITED
    Info
    Registered number 08842973
    Royal Sussex County Hospital, Eastern Road, Brighton BN2 5BE
    Private Limited Company incorporated on 2014-01-13 (11 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-13
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.